RNA
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
RNA
Delisted
RNA was delisted on the 11th of February, 2015.
42 hedge funds and large institutions have $263M invested in PROSENSA HLDGS N V ORD SHS (NLD) in 2014 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
62% more funds holding
Funds holding: 26 → 42 (+16)
70% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 10
Holders
42
Holding in Top 10
2
Calls
$9.04M
Puts
$3.11M
Top Buyers
| 1 | +$10.9M | |
| 2 | +$7.3M | |
| 3 | +$3.53M | |
| 4 |
O
OrbiMed
New York
|
+$3.33M |
| 5 |
Axa
Paris,
France
|
+$3.14M |
Top Sellers
| 1 | -$12.7M | |
| 2 | -$626K | |
| 3 | -$259K | |
| 4 |
AGM
Alpine Global Management
New York
|
-$169K |
| 5 |
Citigroup
New York
|
-$150K |